Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Concurrent Serotonin Syndrome and Hyponatremia: A Case Report and Review

Forouzan Elyasi 1 , 2 , * and Marzieh Azizi 3
Authors Information
1 Department of Psychiatry, School of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, IR Iran
3 Students Research Committee, Nasibeh Nursing and Midwifery Faculty, Mazandaran University of Medical Science, Sari, Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: December 2017, 11 (4); e8013
  • Published Online: June 11, 2017
  • Article Type: Case Report
  • Received: August 12, 2016
  • Revised: November 18, 2016
  • Accepted: April 15, 2017
  • DOI: 10.5812/ijpbs.8013

To Cite: Elyasi F, Azizi M. Concurrent Serotonin Syndrome and Hyponatremia: A Case Report and Review, Iran J Psychiatry Behav Sci. 2017 ; 11(4):e8013. doi: 10.5812/ijpbs.8013.

Copyright © 2017, Iranian Journal of Psychiatry and Behavioral Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. 2013;13(4):533-40. [PubMed: 24358002].
  • 2. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148(6):705-13. doi: 10.1176/ajp.148.6.705. [PubMed: 2035713].
  • 3. Katherine B, Paley MSN. Psychopharmacology grand rounds. New Haven: Yale University School of Nursing; 2003.
  • 4. Guay D. Hyponatremia associated with selective serotonin reuptake inhibitors: clinical review. Consult Pharmacist. 2000;15:160-77.
  • 5. Naranjo CA, Bremner KE. Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption. Alcohol Alcohol Suppl. 1993;2:221-9. [PubMed: 7748304].
  • 6. Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry. 2002;17(3):231-7. [PubMed: 11921151].
  • 7. Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47(2):211-7. [PubMed: 10190657].
  • 8. Rosner MH, Dalkin AC. Electrolyte disorders associated with cancer. Adv Chronic Kidney Dis. 2014;21(1):7-17. doi: 10.1053/j.ackd.2013.05.005. [PubMed: 24359982].
  • 9. Fisher A, Davis M, Croft-Baker J, Purcell P, McLean A. Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review. Adverse Drug React Toxicol Rev. 2002;21(4):179-87. [PubMed: 12503252].
  • 10. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006;40(9):1618-22. doi: 10.1345/aph.1G293. [PubMed: 16896026].
  • 11. Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med. 1998;16(4):615-9. [PubMed: 9696181].
  • 12. Javadkar A, Javadkar N, Pande N, Saldanha D. SSRI-induced hyponatremia. Med JDY Patil Univ. 2014;7:404-6.
  • 13. Odeh M, Seligmann H, Oliven A. Severe life-threatening hyponatremia during paroxetine therapy. J Clin Pharmacol. 1999;39(12):1290-1. [PubMed: 10586396].
  • 14. Flint AJ, Crosby J, Genik JL. Recurrent hyponatremia associated with fluoxetine and paroxetine. Am J Psychiatry. 1996;153(1):134. [PubMed: 8540575].
  • 15. Odeh M, Beny A, Oliven A. Severe symptomatic hyponatremia during citalopram therapy. Am J Med Sci. 2001;321(2):159-60. [PubMed: 11217819].
  • 16. Leung VP, Chiu HF, Lam LC. Hyponatremia associated with paroxetine. Pharmacopsychiatry. 1998;31(1):32-4. doi: 10.1055/s-2007-979293. [PubMed: 9524983].
  • 17. Arinzon ZH, Lehman YA, Fidelman ZG, Krasnyansky ,I. Delayed recurrent SIADH associated with SSRIs. Ann Pharmacother. 2002;36(7-8):1175-7. doi: 10.1345/aph.1A337. [PubMed: 12086550].
  • 18. Bigaillon C, El Jahiri Y, Garcia C, Hejl-Garcia C, Mayaudon H, Ceppa F, et al. [Inappropriate ADH secretion-induced hyponatremia and associated with paroxetine use]. Rev Med Interne. 2007;28(9):642-4. doi: 10.1016/j.revmed.2007.03.336. [PubMed: 17499890].
  • 19. Flores G, Perez-Patrigeon S, Cobos-Ayala C, Vergara J. Severe symptomatic hyponatremia during citalopram therapy--a case report. BMC Nephrol. 2004;5:2. doi: 10.1186/1471-2369-5-2. [PubMed: 14728721].
  • 20. Suwa A, Wakeno M, Tajika A, Kato M, Sugimoto T, Nishida K, et al. Syndrome of inappropriate secretion of anti-diuretic hormone in an elderly depressive patient receiving paroxetine: a case report. Int J Geriatr Psychiatry. 2010;25(4):433-4. doi: 10.1002/gps.2337. [PubMed: 20222083].
  • 21. Nirmalani A, Stock SL, Catalano G. Syndrome of inappropriate antidiuretic hormone associated with escitalopram therapy. CNS Spectr. 2006;11(6):429-32. [PubMed: 16816780].
  • 22. Viramontes TS, Truong H, Linnebur SA. Antidepressant-induced hyponatremia in older adults. Consult Pharm. 2016;31(3):139-50. doi: 10.4140/TCP.n.2016.139. [PubMed: 26975593].
  • 23. Gabriel A. Serotonin reuptake inhibitor and fluvoxamine-induced severe hyponatremia in a 49-year-old man. Case Rep Med. 2009;2009:585193. doi: 10.1155/2009/585193. [PubMed: 19829765].
  • 24. Siah S, Benziane H, Dami A, Lahlou J, Mahassine F, Chaari J, et al. [Fluoxetine and inappropriate antidiuretic hormone secretion in elderly patients: a case report]. Ann Biol Clin (Paris). 2007;65(4):417-20. [PubMed: 17627924].
  • 25. Choudhry ME. Serotonin syndrome and acute hyponatremia, complex overlapping syndromes, a case report and review. Case Reports Clin Med. 2014;3(2):92-6. doi: 10.4236/crcm.2014.32023.
  • 26. Spigset O, Adielsson G. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction. Int Clin Psychopharmacol. 1997;12(1):61-3. [PubMed: 9179637].
  • 27. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45. [PubMed: 7249508].
  • 28. Beakley BD, Kaye AM, Kaye AD. Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review. Pain Physician. 2015;18(4):395-400. [PubMed: 26218943].
  • 29. Gillman PK. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. J Psychopharmacol. 2011;25(3):429-36. doi: 10.1177/0269881109359098. [PubMed: 20142303].
  • 30. Gillman PK. A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. Biol Psychiatry. 2006;59(11):1046-51. doi: 10.1016/j.biopsych.2005.11.016. [PubMed: 16460699].
  • 31. Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95(4):434-41. doi: 10.1093/bja/aei210. [PubMed: 16051647].
  • 32. Gillman PK, Whyte IM. Serotonin syndrome. In: Haddad P, Dursun S, Deakin B, editors. Adverse syndromes and psychiatric drugs. Oxford: Oxford University Press; 2004. p. 37-49.
  • 33. Ramsey TD, Lau TT, Ensom MH. Serotonergic and adrenergic drug interactions associated with linezolid: a critical review and practical management approach. Ann Pharmacother. 2013;47(4):543-60. doi: 10.1345/aph.1R604. [PubMed: 23548646].
  • 34. Gayle JA, Volpi Abadie J, Kaye AD, Kaye AD. Serotonin syndrome, In essentials of pharmacology for anesthesia, pain medicine, and critical care. New York: Springer-Verlag; 2014. p. 797-807.
  • 35. Moritz ML, Ayus JC. The pathophysiology and treatment of hyponatraemic encephalopathy: an update. Nephrol Dial Transplant. 2003;18(12):2486-91. [PubMed: 14605269].
  • 36. Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin. 2002;20(1):227-39. vii. [PubMed: 11754308].
  • 37. Sparacio RR, Anziska B, Schutta HS. Hypernatremia and chorea. A report of two cases. Neurology. 1976;26(1):46-50. [PubMed: 942769].
  • 38. Siegenthaler W. Differential diagnosis in internal medicine: From symptom to diagnosis. Thieme Medical Publishers. 2007;Stuttgart.
  • 39. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20. doi: 10.1056/NEJMra041867. [PubMed: 15784664].
  • 40. Subedi P, David M. Chooljian Hyponatremia Due To SIADH From Serotonin Syndrome. First published online. 2015.
  • 41. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol. 1999;13(1):100-9. doi: 10.1177/026988119901300111. [PubMed: 10221364].
  • 42. Boyer EW, Traub SJ, Grayzel J. Serotonin syndrome. UpToDate. 2015.
  • 43. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635-42. [PubMed: 12925718].
  • 44. Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. CMAJ. 2003;168(11):1439-42. [PubMed: 12771076].
  • 45. Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ. 2014;348:g1626. doi: 10.1136/bmj.g1626. [PubMed: 24554467].
  • 46. Katherine B. Psychopharmacology grand rounds. New Haven: Yale University School of Nursing; 2003.
  • 47. Seidl LG, Thornton GF, Cluff LE. Epidemiological Studies of Adverse Drug Reactions. Am J Public Health Nations Health. 1965;55:1170-5. [PubMed: 14326412].
  • 48. Cooper BE, Sejnowski CA. Serotonin syndrome: recognition and treatment. AACN Adv Crit Care. 2013;24(1):15-20. quiz 21-2. doi: 10.1097/NCI.0b013e31827eecc6. [PubMed: 23343808].
  • 49. Dvir Y, Smallwood P. Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry. 2008;30(3):284-7. doi: 10.1016/j.genhosppsych.2007.09.007. [PubMed: 18433663].
  • 50. Nisijima K, Shioda K, Yoshino T, Takano K, Kato S. Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochem Int. 2003;43(2):155-64. [PubMed: 12620284].
  • 51. Lappin RI, Auchincloss EL. Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med. 1994;331(15):1021-2. doi: 10.1056/NEJM199410133311514. [PubMed: 8084345].
  • 52. Neuvonen PJ, Pohjola-Sintonen S, Tacke U, Vuori E. Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses. Lancet. 1993;342(8884):1419. [PubMed: 7901695].
  • 53. Power BM, Pinder M, Hackett LP, Ilett KF. Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Anaesth Intensive Care. 1995;23(4):499-502. [PubMed: 7485947].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments